Nimmrich, Inko <br/><br/>
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.  [electronic resource] 

 -  Breast cancer research and treatment  Oct 2008 
 - 429-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0167-6806 
<br/><br/><label>Standard No.: </label>10.1007/s10549-007-9800-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--genetics<br/>Cell Line, Tumor<br/>DNA Methylation<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Homeodomain Proteins--genetics<br/>Humans<br/>Lymph Nodes--pathology<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Prognosis<br/>RNA, Messenger--analysis<br/>Receptors, Steroid--analysis<br/>Retrospective Studies<br/>Survival Analysis<br/>Time Factors<br/>Transcription Factors--genetics<br/>Homeobox Protein PITX2